Ultragenyx Pharmaceutical Inc (RARE)
46.64
+0.24
(+0.51%)
USD |
NASDAQ |
Nov 21, 10:30
Ultragenyx Pharmaceutical Price: 46.64 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 44.91 | 46.98 | 44.90 | 46.40 | 641624.0 |
| Nov 19, 2024 | 43.90 | 45.15 | 43.38 | 45.13 | 1.064M |
| Nov 18, 2024 | 44.50 | 44.92 | 43.04 | 43.78 | 1.040M |
| Nov 15, 2024 | 47.36 | 48.11 | 44.53 | 44.75 | 818886.0 |
| Nov 14, 2024 | 48.41 | 48.60 | 47.59 | 47.64 | 586327.0 |
| Nov 13, 2024 | 48.27 | 49.37 | 47.76 | 48.71 | 1.091M |
| Nov 12, 2024 | 50.28 | 50.48 | 47.72 | 47.84 | 856956.0 |
| Nov 11, 2024 | 50.98 | 53.04 | 50.68 | 50.73 | 1.061M |
| Nov 08, 2024 | 50.80 | 51.45 | 49.96 | 50.36 | 1.247M |
| Nov 07, 2024 | 50.53 | 51.32 | 49.60 | 50.43 | 706142.0 |
| Nov 06, 2024 | 52.56 | 53.47 | 49.27 | 50.52 | 1.612M |
| Nov 05, 2024 | 50.09 | 52.19 | 49.89 | 52.18 | 1.750M |
| Nov 04, 2024 | 50.58 | 51.75 | 49.84 | 51.06 | 2.295M |
| Nov 01, 2024 | 51.14 | 51.84 | 50.83 | 50.99 | 680606.0 |
| Oct 31, 2024 | 51.50 | 52.09 | 50.76 | 50.99 | 833821.0 |
| Oct 30, 2024 | 52.30 | 53.20 | 51.50 | 51.84 | 721993.0 |
| Oct 29, 2024 | 53.33 | 53.48 | 52.38 | 52.80 | 632745.0 |
| Oct 28, 2024 | 54.36 | 55.06 | 52.65 | 53.07 | 922887.0 |
| Oct 25, 2024 | 54.67 | 55.40 | 53.78 | 53.82 | 427150.0 |
| Oct 24, 2024 | 54.51 | 55.22 | 54.19 | 54.82 | 446818.0 |
| Oct 23, 2024 | 54.80 | 56.38 | 54.51 | 54.69 | 518139.0 |
| Oct 22, 2024 | 54.04 | 55.18 | 53.77 | 54.79 | 374760.0 |
| Oct 21, 2024 | 56.16 | 56.20 | 54.28 | 54.46 | 419882.0 |
| Oct 18, 2024 | 56.81 | 57.09 | 56.19 | 56.26 | 310163.0 |
| Oct 17, 2024 | 57.70 | 57.97 | 56.02 | 56.77 | 497778.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
31.73
Minimum
Oct 18 2023
177.39
Maximum
Dec 23 2020
65.50
Average
53.66
Median
Feb 27 2024
Price Benchmarks
| Alnylam Pharmaceuticals Inc | 249.86 |
| NovaBay Pharmaceuticals Inc | 0.7026 |
| Palatin Technologies Inc | 0.95 |
| iBio Inc | 2.34 |
| Theriva Biologics Inc | 1.26 |
Price Related Metrics
| PS Ratio | 7.752 |
| Price to Book Value | 12.42 |
| Earnings Yield | -13.87% |
| Market Cap | 4.306B |